Advertisement
Screener

VERACYTE, INC. (VCYT) Operating Income

VERACYTE, INC. Operating Income

VERACYTE, INC. (VCYT) reported Operating Income of $22.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-07-31

  • VERACYTE, INC. operating income (loss) for the quarter ending 2026-06-30 was $22.98M.
  • VERACYTE, INC. operating income (loss) for the quarter ending 2026-03-31 was $22.65M, a 679.82% increase year-over-year.
  • VERACYTE, INC. operating income (loss) for the quarter ending 2025-12-31 was $37.20M, a 790.90% increase year-over-year.
  • VERACYTE, INC. operating income (loss) for the quarter ending 2025-09-30 was $22.95M, a 90.95% increase year-over-year.
  • VERACYTE, INC. operating income (loss) for fiscal 2025 was $57.78M, a 257.93% increase from fiscal 2024.
  • VERACYTE, INC. operating income (loss) for fiscal 2024 was $16.14M.
  • VERACYTE, INC. operating income (loss) for fiscal 2023 was -$85.80M.
  • VERACYTE, INC. operating income (loss) for fiscal 2022 was -$41.08M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30$22.98M
10-Q · filed 2026-07-31
$45.63M
10-Q · filed 2026-07-31
$82.82M
derived: sum of 3 quarters · filed 2026-07-31
$105.77M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$22.65M
10-Q · filed 2026-05-06
$59.84M
derived: sum of 2 quarters · filed 2026-05-06
$82.79M
derived: sum of 3 quarters · filed 2026-05-06
$77.52M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$37.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$60.14M
derived: sum of 2 quarters · filed 2026-02-26
$54.87M
derived: sum of 3 quarters · filed 2026-07-31
$57.78M
10-K · filed 2026-02-26
2025-09-30$22.95M
10-Q · filed 2025-11-05
$17.68M
derived: sum of 2 quarters · filed 2026-07-31
$20.58M
10-Q · filed 2025-11-05
$24.76M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30-$5.27M
10-Q · filed 2026-07-31
-$2.36M
10-Q · filed 2026-07-31
$1.81M
derived: sum of 3 quarters · filed 2026-07-31
$13.83M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$2.90M
10-Q · filed 2026-05-06
$7.08M
derived: sum of 2 quarters · filed 2026-05-06
$19.10M
derived: sum of 3 quarters · filed 2026-05-06
$23.70M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$4.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$16.19M
derived: sum of 2 quarters · filed 2026-02-26
$20.80M
derived: sum of 3 quarters · filed 2026-02-26
$16.14M
10-K · filed 2026-02-26
2024-09-30$12.02M
10-Q · filed 2025-11-05
$16.62M
derived: sum of 2 quarters · filed 2025-11-05
$11.97M
10-Q · filed 2025-11-05
-$23.54M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$4.61M
10-Q · filed 2025-08-07
-$50.00K
10-Q · filed 2025-08-07
-$35.56M
derived: sum of 3 quarters · filed 2026-02-26
-$67.30M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$4.66M
10-Q · filed 2025-05-08
-$40.16M
derived: sum of 2 quarters · filed 2026-02-26
-$71.90M
derived: sum of 3 quarters · filed 2026-02-26
-$79.95M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$35.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$67.25M
derived: sum of 2 quarters · filed 2026-02-26
-$75.30M
derived: sum of 3 quarters · filed 2026-02-26
-$85.80M
10-K · filed 2026-02-26
2023-09-30-$31.74M
10-Q · filed 2024-11-07
-$39.79M
derived: sum of 2 quarters · filed 2024-11-07
-$50.29M
10-Q · filed 2024-11-07
-$55.71M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$8.05M
10-Q · filed 2024-08-07
-$18.55M
10-Q · filed 2024-08-07
-$23.97M
derived: sum of 3 quarters · filed 2025-02-28
-$33.65M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$10.50M
10-Q · filed 2024-05-08
-$15.92M
derived: sum of 2 quarters · filed 2025-02-28
-$25.60M
derived: sum of 3 quarters · filed 2025-02-28
-$36.33M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$5.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$15.10M
derived: sum of 2 quarters · filed 2025-02-28
-$25.83M
derived: sum of 3 quarters · filed 2025-02-28
-$41.08M
10-K · filed 2025-02-28
2022-09-30-$9.68M
10-Q · filed 2023-11-08
-$20.41M
derived: sum of 2 quarters · filed 2023-11-08
-$35.66M
10-Q · filed 2023-11-08
-$47.99M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$10.73M
10-Q · filed 2023-08-09
-$25.98M
10-Q · filed 2023-08-09
-$38.31M
derived: sum of 3 quarters · filed 2024-02-29
-$54.99M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$15.25M
10-Q · filed 2023-05-05
-$27.58M
derived: sum of 2 quarters · filed 2024-02-29
-$44.26M
derived: sum of 3 quarters · filed 2024-02-29
-$51.74M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$12.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$29.01M
derived: sum of 2 quarters · filed 2024-02-29
-$36.49M
derived: sum of 3 quarters · filed 2024-02-29
-$81.90M
10-K · filed 2024-02-29
2021-09-30-$16.68M
10-Q · filed 2022-11-03
-$24.16M
derived: sum of 2 quarters · filed 2022-11-03
-$69.57M
10-Q · filed 2022-11-03
-$77.64M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$7.47M
10-Q · filed 2022-08-03
-$52.89M
10-Q · filed 2022-08-03
-$60.96M
derived: sum of 3 quarters · filed 2023-03-01
-$65.03M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$45.41M
10-Q · filed 2022-05-04
-$53.49M
derived: sum of 2 quarters · filed 2023-03-01
-$57.55M
derived: sum of 3 quarters · filed 2023-03-01
-$68.60M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$8.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$12.14M
derived: sum of 2 quarters · filed 2023-03-01
-$23.19M
derived: sum of 3 quarters · filed 2023-03-01
-$35.39M
10-K · filed 2023-03-01
2020-09-30-$4.07M
10-Q · filed 2021-11-09
-$15.12M
derived: sum of 2 quarters · filed 2021-11-09
-$27.32M
10-Q · filed 2021-11-09
-$35.51M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30-$11.05M
10-Q · filed 2021-07-29
-$23.25M
10-Q · filed 2021-07-29
-$31.45M
derived: sum of 3 quarters · filed 2022-02-28
-$33.21M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$12.20M
10-Q · filed 2021-05-10
-$20.40M
derived: sum of 2 quarters · filed 2022-02-28
-$22.16M
derived: sum of 3 quarters · filed 2022-02-28
-$25.26M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$8.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$9.96M
derived: sum of 2 quarters · filed 2022-02-28
-$13.06M
derived: sum of 3 quarters · filed 2022-02-28
-$15.13M
10-K · filed 2022-02-28
2019-09-30-$1.76M
10-Q · filed 2020-11-02
-$4.86M
derived: sum of 2 quarters · filed 2020-11-02
-$6.93M
10-Q · filed 2020-11-02
-$9.99M
derived: sum of 4 quarters · filed 2021-02-22
2019-06-30-$3.10M
10-Q · filed 2020-07-30
-$5.17M
10-Q · filed 2020-07-30
-$8.22M
derived: sum of 3 quarters · filed 2021-02-22
-$12.53M
derived: sum of 4 quarters · filed 2021-02-22
2019-03-31-$2.07M
10-Q · filed 2020-05-06
-$5.12M
derived: sum of 2 quarters · filed 2021-02-22
-$9.43M
derived: sum of 3 quarters · filed 2021-02-22
-$15.35M
derived: sum of 4 quarters · filed 2021-02-22
2018-12-31-$3.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22
-$7.36M
derived: sum of 2 quarters · filed 2021-02-22
-$13.28M
derived: sum of 3 quarters · filed 2021-02-22
-$22.23M
10-K · filed 2021-02-22
2018-09-30-$4.30M
10-Q · filed 2019-10-22
-$10.22M
derived: sum of 2 quarters · filed 2019-10-22
-$19.18M
10-Q · filed 2019-10-22
-$25.22M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30-$5.92M
10-Q · filed 2019-07-30
-$14.87M
10-Q · filed 2019-07-30
-$20.92M
derived: sum of 3 quarters · filed 2020-02-25
-$27.28M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$8.96M
10-Q · filed 2019-04-30
-$15.00M
derived: sum of 2 quarters · filed 2020-02-25
-$21.37M
derived: sum of 3 quarters · filed 2020-02-25
-$27.98M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31-$6.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$12.41M
derived: sum of 2 quarters · filed 2020-02-25
-$19.02M
derived: sum of 3 quarters · filed 2020-02-25
-$26.54M
10-K · filed 2020-02-25
2017-09-30-$6.37M
10-Q · filed 2018-10-29
-$12.98M
derived: sum of 2 quarters · filed 2018-10-29
-$20.49M
10-Q · filed 2018-10-29
-$24.17M
derived: sum of 4 quarters · filed 2019-02-25
2017-06-30-$6.61M
10-Q · filed 2018-07-23
-$14.13M
10-Q · filed 2018-07-23
-$17.80M
derived: sum of 3 quarters · filed 2019-02-25
-$22.68M
derived: sum of 4 quarters · filed 2019-02-25
2017-03-31-$7.52M
10-Q · filed 2018-05-01
-$11.19M
derived: sum of 2 quarters · filed 2019-02-25
-$16.07M
derived: sum of 3 quarters · filed 2019-02-25
-$26.57M
derived: sum of 4 quarters · filed 2019-02-25
2016-12-31-$3.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
-$8.56M
derived: sum of 2 quarters · filed 2019-02-25
-$19.05M
derived: sum of 3 quarters · filed 2019-02-25
-$28.80M
10-K · filed 2019-02-25
2016-09-30-$4.89M
10-Q · filed 2017-11-07
-$15.38M
derived: sum of 2 quarters · filed 2017-11-07
-$25.13M
10-Q · filed 2017-11-07
-$33.08M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$10.49M
10-Q · filed 2017-07-31
-$20.25M
10-Q · filed 2017-07-31
-$28.20M
derived: sum of 3 quarters · filed 2018-02-27
-$37.08M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$9.75M
10-Q · filed 2017-05-03
-$17.70M
derived: sum of 2 quarters · filed 2018-02-27
-$26.59M
derived: sum of 3 quarters · filed 2018-02-27
-$35.66M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$7.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$16.84M
derived: sum of 2 quarters · filed 2018-02-27
-$25.91M
derived: sum of 3 quarters · filed 2018-02-27
-$33.47M
10-K · filed 2018-02-27
2015-09-30-$8.89M
10-Q · filed 2016-11-03
-$17.96M
derived: sum of 2 quarters · filed 2016-11-03
-$25.52M
10-Q · filed 2016-11-03
-$33.57M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30-$9.07M
10-Q · filed 2016-08-03
-$16.63M
10-Q · filed 2016-08-03
-$24.69M
derived: sum of 3 quarters · filed 2017-03-01
-$32.50M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$7.55M
10-Q · filed 2016-05-05
-$15.61M
derived: sum of 2 quarters · filed 2017-03-01
-$23.42M
derived: sum of 3 quarters · filed 2017-03-01
-$29.98M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$8.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$15.87M
derived: sum of 2 quarters · filed 2017-03-01
-$22.43M
derived: sum of 3 quarters · filed 2017-03-01
-$29.01M
10-K · filed 2017-03-01
2014-09-30-$7.81M
10-Q · filed 2015-11-05
-$14.37M
derived: sum of 2 quarters · filed 2015-11-05
-$20.95M
10-Q · filed 2015-11-05
-$26.71M
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30-$6.56M
10-Q · filed 2015-08-13
-$13.14M
10-Q · filed 2015-08-13
-$18.90M
derived: sum of 3 quarters · filed 2016-03-14
-$25.00M
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31-$6.58M
10-Q · filed 2015-05-15
-$12.34M
derived: sum of 2 quarters · filed 2016-03-14
-$18.44M
derived: sum of 3 quarters · filed 2016-03-14
-$23.86M
derived: sum of 4 quarters · filed 2016-03-14
2013-12-31-$5.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
-$11.86M
derived: sum of 2 quarters · filed 2016-03-14
-$17.28M
derived: sum of 3 quarters · filed 2016-03-14
-$23.17M
10-K · filed 2016-03-14
2013-09-30-$6.10M
10-Q · filed 2014-11-13
-$11.52M
derived: sum of 2 quarters · filed 2014-11-13
-$17.41M
10-Q · filed 2014-11-13
-$22.53M
derived: sum of 4 quarters · filed 2015-03-25
2013-06-30-$5.42M
10-Q · filed 2014-08-14
-$11.31M
10-Q · filed 2014-08-14
-$16.43M
derived: sum of 3 quarters · filed 2015-03-25
-$21.36M
derived: sum of 4 quarters · filed 2015-03-25
2013-03-31-$5.89M
10-Q · filed 2014-05-09
-$11.01M
derived: sum of 2 quarters · filed 2015-03-25
-$15.95M
derived: sum of 3 quarters · filed 2015-03-25
2012-12-31-$5.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
-$10.05M
derived: sum of 2 quarters · filed 2015-03-25
-$18.93M
10-K · filed 2015-03-25
2012-09-30-$4.94M
10-Q · filed 2013-11-25
-$13.81M
10-Q · filed 2013-11-25
2011-12-31-$15.27M
10-K · filed 2014-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B